Enterococcus faecium is a commensal but also a bacteremia causing pathogen, which is inherently resistant to several antimicrobials and has a great ability to acquire new traits. Bacterial membrane vesicles (MVs) are increasingly recognized as a mode of cell-free communication and a way to deliver virulence factors and/or antimicrobial resistance determinants. These features make MVs interesting research targets in research on critical hospital pathogens. This study describes for the first time that E. faecium strains produce MVs. It presents a morphological as well as a proteomic analysis of MVs isolated from four different, clinically relevant E. faecium strains grown under two different conditions and identifies MV-associated proteins in all of them. Interestingly, 11 virulence factors are found among the MV-associated proteins, including biofilm-promoting proteins and extracellular matrix-binding proteins, which may aid in enterococcal colonization. Additionally, 11 antimicrobial resistance-related proteins were MV-associated. Among those, all proteins encoded by the vanA-cluster of a vancomycin resistant strain were found to be MV-associated. This implies that E. faecium MVs may be utilized by the bacterium to release proteins promoting virulence, pathogenicity and antimicrobial resistance. Significance: Enterococcal infections, especially bacteremia and endocarditis, are challenging to treat because E. faecium have acquired resistance to multiple classes of antimicrobials, including ampicillin, aminoglycosides, and glycopeptides. Thus, research on different modes of enterococcal pathogenicity is warranted. This study utilized a proteomic approach to identify MV-associated proteins of different nosocomial E. faecium strains representing four clinically relevant sequence types (STs), namely ST17, ST18, ST78, and ST192. The presented data suggest that E. faecium MVs are involved in virulence and antimicrobial resistance.
Introduction
Enterococci are Gram-positive, ubiquitous, facultative anaerobic cocci. They are known to survive hostile conditions such as a saline environment and wide temperature ranges and also for their ability to persist long-term in the hospital environment [1] . Enterococcus faecalis and Enterococcus faecium naturally colonize the human gut as commensals. However, E. faecium in particular has undergone a pronounced transition towards a multi-drug resistant pathogen. The most common infection caused by E. faecium is urinary tract infection, but they may also cause life-threatening infections such as endocarditis and bacteremia, especially in debilitated patients [2] . The genetic clade structure of E. faecium is characterized by a distinct split of commensal lineage (clade B) and hospital-associated lineage (clade A1) [3] . The nosocomial A1 clade includes sequence types (STs) of the clonal complex 17 (CC17), a globally spread genetic complex characterized by ampicillin resistance, possession of a pathogenicity island and association with hospital outbreaks [4] .
Extracellular vesicles are suggested as a mechanism for cell-free intercellular communication across all domains of life. They are crucial components of the bacterial secretome, as these 20-200 nm sized spheres contain lipopolysaccharides, soluble membrane-associated proteins, virulence factors and nucleic acids [5, 6] .
Bacterial membrane vesicles were first described in the Gram- negative Escherichia coli in the 1960s [7, 8] , and later in several other Gram-negative species such as Shigella sp. [9] , Salmonella sp. [10] , and Vibrio sp. [11] . In Gram-negative bacteria, the vesicles are called outermembrane vesicles (OMVs), as they derive from the outer membrane (OM). The OMVs contain OM components as well as inner membrane constituents and cytoplasmic elements. The role of OMVs in bacterial physiology and pathogenesis, stress responses, biofilm formation as well as secretion and delivery of biomolecules has been demonstrated [12] . The mechanism of vesiculogenesis is poorly understood but seems to involve phospholipid accumulation in the outer leaflet of the outer membrane, whereupon vesicles pinch off from the outer membrane among Gram-negative bacteria [13] . It used to be a long-standing assumption that the thick cell wall of Gram-positive bacteria precluded the existence of vesicles, as they could not escape such a barrier. Gram-positive MVs were discovered in a study from the early 1990s in Bacillus cereus and Bacillus subtilis [14] , but not further characterized for the next 20 years. Finally, in 2009 MVs were described in Staphylococcus aureus [15] and have since gained increased attention, i.e. in Bacillus anthracis [16] , Mycobacterium tuberculosis [17] and others, as reviewed by Brown et al. [6] . MVs are key players in host-pathogen interactions, as they can cause disease without the living bacterial cell [18] and may induce strong host responses [19] .
MV production in enterococci has not been described previously. The aim of this study was therefore to explore the potential of MVs release from E. faecium. In addition, we investigated whether different cultural conditions and strain backgrounds may account for variation in proteinaceous cargo. Four strains representing different, clinically important sequence types (STs) within CC17, the major disease causing clonal complex [20] : ST17, ST18, ST78, and ST192 respectively, were therefore chosen for the study. To the best of our knowledge, this is the first report describing MV release by clinical strains of enterococci and their proteomics-based characterization using an in-solution approach.
Materials and methods

Strains and growth conditions
In the present study, the E. faecium strains DO (PRJNA71), E155 (PRJNA192879), K59-68 (in-house sequenced, under submission) and K60-39 (PRJNA407052), representing ST 18, 17, 78 and 192 , respectively, were used. They are hospital isolates either from the US or Norway. Their properties and additional information are presented in Table 1 .
E. faecium strains were routinely cultured on brain heart infusion (BHI) or Luria Bertani (LB) agar or in liquid BHI or LB at 37°C.
Isolation of membrane vesicles
Vesicles were isolated as described for S. aureus [16, 21] with a few modifications.
First, to isolate vesicles from bacteria mainly in a viable state, cultures in mid-exponential growth phase grown in nutrient-rich BHI were used (Fig. S1A) . Therefore, 1 L of BHI broth were inoculated with enterococci grown overnight in BHI broth (1100) and grown at 37°C with shaking (230 rpm) to mid-exponential phase (optical density at 600 nm [OD 600 ], approximately 1.5). The cultures were centrifuged at 6000 ×g for 30 min with a JLA 9.1000 rotor Beckman Instruments Inc., USA) and the supernatant was transferred to a clean Erlenmeyer flask and filtered through a 0.22 μm pore size filter (Merck Millipore, USA). The obtained bacterial-free filtrate was concentrated using Amicon tubes (Merck Millipore, USA, cut off 100 kDa) in a "Beckman" centrifuge at 4000 ×g for 30 min at 4°C and the concentrate was ultracentrifuged using a SW 40-TI rotor (20,000 x g for 3 h at 4°C) to pellet MVs. The MVs were washed in phosphate-buffered saline (PBS) followed by another ultracentrifugation, before re-suspention in PBS. Purified MVs were stored at −80°C until further analysis. Purified MVs were streaked onto BHI agar 
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to confirm the sterility of isolated MVs. Second, in order to isolate vesicles from bacteria under stress, bacterial stationary phase cultures grown in growth-limiting LB were used (Fig. S1B ). For this, the above-described procedure was applied to enterococcal overnight cultures grown in LB.
Density gradient centrifugation (DGC)
DGC was performed in order to fractionate and purify the MVs further. Therefore, the MV sample was mixed with an equal volume of ice-cold 60% OptiPrep (Sigma-Aldrich, Germany; 60% stock) to obtain a 30% solution. The 30% solution was transferred into the bottom of an ultracentrifugation tube (ultraClear™, 5 mL, 13 × 51 mm, Beckman Instruments Inc., USA) and 2 mL of 25% (w/v), 1 mL of 5% (w/v) OptiPrep solution and PBS were added. Centrifugation was carried out at 100000 ×g for 3 h at 4°C (rotor SW 50.1, Beckman Instruments Inc., USA) in slow acceleration and deceleration mode to prevent disturbance in the various density layers and achieve MV ring formation (see example in Fig. S2A ). After centrifugation, the sample was divided into 200 μL fractions, which were transferred into clean Eppendorf tubes. Aliquots of the fractions were analyzed by SDS PAGE (see example in Fig. S2B ) and electron microscopy.
To remove the OptiPrep solution, the fractions containing MVs were pooled and concentrated by ultrafiltration (10 kDa molecular weight cut-off, Vivaspin 20, Sartorius, Germany) at 4000 ×g for 30 min at 4°C and re-suspended in 200 μL PBS.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
Protein profiling of isolated MVs from all the four strains of enterococci was determined by SDS-PAGE using standard molecular stain. Briefly, 15 μL of MV sample were mixed with 5.75 μL 4× NuPage LDS sample buffer (NuPage Novex 4-12%; Invitrogen, Life Technologies, USA) as well as 2.3 μL of dithiothreitol (DTT) and heated for 10 min at 70°C prior to electrophoresis. Samples were separated by 12% NuPage Bis-Tris SDS-PAGE gel, and the gels were fixed in fixation solution (methanol, acetic acid (50/50 v/v)) for 1 h at room temperature under gentle agitation. The gels were then stained with Coomassie solution (50% methanol, 10% acetic acid, 0.05% Coomassie brilliant blue R-250, Thermo Fisher Scientific USA) for 1 h and excess dye was removed through incubation in de-stain solution (H 2 O, methanol, acetic acid (50/40/10 v/v/v)) until bands were visible.
Transmission electron microscopy (TEM) analysis
Five μL of purified MVs were applied to Formvar coated 75 mesh copper grids (Electron Microscopy Science, USA) and incubated for 5 min. The sample was washed four times with double distilled water and negatively stained with 9 parts of 2% methylcellulose and 1 part of 3% uranyl acetate for 2 min on ice. The excess stain was removed and samples were dried at room temperature. The samples were then visualized with a JEOL JEM 1010 transmission electron microscope (JEOL, Japan) operated at 80 kV.
Atomic force microscopy (AFM) analysis
AFM analysis of E. faecium strains DO and E155 cultivated on LB agar were performed as described previously [22] . A loop of bacterial cells was suspended in ultrapure water and placed on a freshly cleaved mica surface, incubated at room temperature and ultimately blotted dry before being placed into a desiccator. Imaging was carried out using a Nanoscope V Atomic Force Microscope (Bruker AXS, Germany).
Particle size distribution and measurement of zeta potential
The effective diameter and size distribution of the purified MVs were determined by dynamic light scattering (DLS, also known as photon correlation spectroscopy) (Nicomp Submicron Particle Sizer 370, PSS Nicomp Particle Sizing Systems, USA), at an angle of 90°with a 632 nm laser as described in an earlier study [23] . Briefly, MVs were diluted in PBS in a particle-free environment to a count rate of 250-350 kHz at room temperature. Analyses were run in a vesicle mode data calculated as intensity weighted distribution from three measuring cycles (10 min cycle, 3 cycles) The zeta (ζ) potential of vesicles was determined using Zetasizer Nano Z (Malvern Instruments, United Kingdom). Three parallels were determined for each vesicle suspension.
Measurement of MV-derived protein per CFU
The protein content of isolated and purified MVs from bacterial culture (2 L) was measured by Bradford assay (Bio Rad, USA). For each strain, CFUs per mL were assessed by plating dilution series on blood agar plates and counting CFUs. With these two values, MV-derived protein in attogram (ag) per CFU was calculated from these two values.
Lipid staining of purified vesicles
The purified membrane vesicles were stained for 1 h with lipidspecific dye (5 μM of DiD, Thermo Fisher Scientific, USA). The stained vesicles were then ultra-centrifuged at a speed of 100,000 × g for 1 h at 4°C. The pellets were re-suspended in 20 μL PBS mounted on a glass slide and examined using a confocal microscope (Leica Microsystems CMS GmbH, Germany), with an excitation and emission spectra for DiD at λ 638nm and λ 700nm , respectively.
Detection of peptidoglycan
ELISA was used to assess the presence of peptidoglycan, which was exposed by incubating the membrane vesicles and bacteria with 25 mM HCl for 1 h at room temperature under shaking. Microtiter plates (Maxisorb, Thermo Fischer Scientific, USA) were coated with membrane vesicles or bacteria in coating buffer (100 mM Sodium carbonate/ bicarbonate, pH 9.6) at 4°C overnight. After 4 washes with PBS-T (PBS with 0.01% Tween), plates were blocked with 0.05% BSA for 2 h at 37°C and washed. To evaluate the presence of peptidoglycan in the samples, mouse anti-bacterial peptidoglycan monoclonal antibody (IgG, MAB995, Chemicon, Merck Millipore, USA; 1:1000) was added, and the plate incubated for 2 h at 37°C. Excess primary antibody was removed by additional washing with PBS-T, before it was detected with peroxidase-conjugated rabbit anti-mouse immunoglobulin (DAKO, Agilent, USA; 1:500) for 20 min at 37°C. Thereafter, tetramethylbenzidine (3, 3′, 5, 5′-TMB, Sigma Aldrich, Germany) was added as peroxidase substrate, and the reaction was stopped with sulfuric acid upon color change. Absorption was measured at 450 nm.
MV-associated protein identification by mass spectrometry
The protein concentration within the MVs was quantified, and 20 μg MV proteins were re-suspended in 8 M urea. The sample was reduced by adding 20 mM DTT and alkylated with 40 mM iodoacetamide. Alkylation was quenched by 10 mM DTT. Proteins were digested 4 h by 1:100 (w/w) lysyl endopeptidase (Wako Biochemicals, USA). The sample was diluted to 1 M urea and digested overnight by 1/20 (w/w) trypsin (V511A, Promega, USA). OMIX C18 tips (Varian Inc., USA) were used for sample cleanup and concentration. Peptide mixtures containing 0.1% formic acid were loaded onto an EASY-nLC1000 system (Thermo Fisher Scientific, USA) and EASY-Spray column (C18, 2 μm, 100 Å, 50 μm, 50 cm). Peptides were fractionated using a 2-100% acetonitrile gradient in 0.1% formic acid over 50 min at a flow rate of 250 nL/min. The separated peptides were analyzed using a Q-Exactive mass spectrometer (Thermo Fisher Scientific, USA). Data were collected in data-dependent mode using a Top10 method. The raw data were processed using the Proteome Discoverer 2.1 software. The fragmentation spectra were searched against the predicted proteome from the whole genome sequence (WGS) data of the strain itself using the Sequest HT program. Peptide mass tolerances used in the search were 10 ppm, and fragment mass tolerance was 0.02 Da. Peptide ions were filtered using a false discovery rate (FDR) set to 5% for protein identifications.
The MV-associated proteins were identified in 3 biological replicates of MV derived from bacteria in the exponential growth phase in BHI, and are represented as one in the results table without restrictions (Supplementary table S1 ). For MV derived from bacteria in the stationary growth phase in LB one biological replicate is described in the result table (Supplementary table S1 ).
Bioinformatic characterization of identified MV proteins
To evaluate MV-associated proteins, the entire proteomes were classified into core and strain(s)-specific. The core proteome was assigned with the proteins shared by all four strains whereas the strain(s)-specific proteome had proteins found only in one or few strains. All proteins were clustered using CD-HIT with default settings [24] . Homologous clusters possessing at least one protein from each strain were categorized into core proteins, if not as strain(s)-specific proteins.
Overlapping protein content among MVs isolated from four different strains was demonstrated using Venny 2.0 [25] . These results were shown individually for proteomes of MVs isolated after growth in LB to stationary phase and in BHI to mid-exponential phase.
Prediction of signal peptide cleavage sites was performed in SignalP 4.1 [26] and PrediSi [27] on all proteins identified in the MV proteomes. The subcellular localization of identified proteins was predicted using PSORTb version 3.0 [28] . Gene-term enrichment analysis was performed with DAVID Functional Annotation Tool [29] on proteins with an exponentially modified protein abundance index (empai) above 1.
Selected virulence factors and vaccine candidates were searched for using BLAST [30] .
Antimicrobial resistance genes were identified within the respective genomes of the bacterial strains using ResFinder 3.0 [31] with an ID threshold of 90% and a minimum length of 60%. Genes with < 100% ID threshold and 100% minimum length are indicated in Table 2 . Identified genes are aph(3′)-III, aac(6′)-aph(2″); vanR-A, vanS-A, vanH-A, van-A, vanX-A, vanY-A, vanZ-A, vanR-B, vanS-B, vanY-B, vanW-B, vanH-B, vanB, vanX-B; ermB, lnuB, msrC, tetM and dfrG. The corresponding proteins were searched for in the MV proteome in order to identify MV-associated antimicrobial resistance determinants.
Results
Clinical E. faecium strains produce MVs
This study explored whether four different clinical E. faecium strains, belonging to distinct hospital adapted high-risk STs, were able to release membrane vesicles in vitro. Notably, the growth rates of the examined strains at the measured intervals showed only minor variation (Fig. S1 ).
MVs were isolated from E. faecium strains, which were grown in BHI until mid-exponential phase (OD 600 approximately 1.5). To ensure purity of the vesicles from cellular debris and protein aggregates, MVs were further purified and fractionated by gradient centrifugation (Fig.  S2A) . The purified MVs were analyzed by TEM where the presence of vesicle-like circular shape structures was confirmed (Fig. 1A) . Similar structures were detected for the other three examined strains (results not shown). AFM was conducted as a complementary approach and revealed release of MVs by the bacteria to the surrounding environment (Fig. 1B) . To measure the size distribution of larger populations of MVs from the four E. faecium strains, dynamic light scattering (DLS) was employed. While all strains generated MVs of various sizes, the average size of enterococcal MVs ranged from 37 ± 23 nm in the E155 strain to 83 ± 29 nm in the K59-68 strain (Fig. 1C and Table 1 ). Furthermore, the size measured by DLS corresponded to the results obtained from TEM images (Fig. 1A-C, Table 1 ).
Based on protein content, the amount of MVs produced by the four strains ranged from 1.2 ag/CFU in strain K59-68 to 14.6 ag/CFU in strain E155 (Fig. 1D) .
To gain insight into the interaction of the MVs in the colloidal system and gain a better understanding of their physiochemical properties (aggregation, flocculation or dispersion), the membrane (ζ-) potential, of the MVs was measured. The ζ-potential was calculated upon measuring particles electrophoretic mobility. The E. faecium MV surface charge in all examined strains was found to be negative in PBS and reproducible (Table 1) demonstrating a high quality of the MV isolation.
To further characterize the vesicle properties, the purified MVs of strain E155 were stained with a lipophilic fluorescent dye (DiD) for detection of lipids. The confocal microscopy analysis of the stained MVs confirmed the presence of lipids in MVs (Fig. 2A) . The presence of peptidoglycan in the isolated MVs from all four strains was evaluated using a competitive ELISA approach. Interestingly, peptidoglycan could be detected in E. faecium-derived MVs from all examined strains. E. faecium cells were included as a positive peptidoglycan control for this particular assay (Fig. 2B ).
Different cultural conditions and strain backgrounds account for variation in enterococcal MV proteinaceous cargo
To investigate whether the MV protein cargo is strain dependent and influenced by different conditions, the four strains were grown to exponential phase in a nutritious media, BHI, and to stationary phase in a growth-limiting media, LB. MVs were isolated and purified further by gradient centrifugation, and proteomic analysis was performed using an in-solution approach.
Proteomic analyses demonstrated variability in the number of identified proteins among MV-associated proteins isolated from the four selected strains grown in BHI and LB (Supplementary Tables 1-8) .
Comparison of shared versus unique proteins revealed that, in exponential growth in BHI, a lower number (19.2%) of MV-associated proteins was shared than in stationary growth in LB (36.9%), as illustrated in Fig. 3 . MVs from K60-39 showed the highest number of total MV-associated proteins and consequently also possess most unique MVassociated proteins under both conditions. In contrast, MVs from K59-68 showed a lower number of total vesicle associated proteins and accordingly the lowest number of unique proteins.
Based on the sequence similarity of the entire proteome encoded by all four genomes, homologous proteins present in all four were classified as core and the remaining as accessory. Accordingly, the MV-associated proteins were categorized based on their occurrence either in core or accessory proteome. Notably, it was found that 88-91% of the MV-associated proteins are from the core proteome (Table 1) .
The predicted cellular localization of proteins encoded by the whole genome based on WGS data and the origin of MV-associated proteins was predicted by PSORTb. The predicted localization of proteins showed a common pattern among strains and MV-associated proteins originating from two different conditions (Fig. 4) . As expected, most of the MV-associated proteins were predicted as either cytoplasmic or part of the cytoplasmic membrane proteins. A minor number of cell wall or extracellular bound proteins were also predicted in the derived MVs.
SignalP and PrediSi were applied to predict the presence of signal peptides. Although the number of identified proteins varied substantially between strains and conditions, the percentage of putative secreted proteins was comparable (Fig. 5) . In all strains 4-5% of the ORFs encode secreted proteins in the whole genome proteomes, while 10-22% secreted proteins were predicted in MVs derived from exponential growth phase in BHI, and 5-12% secreted proteins in MVs derived from stationary growth phase in LB. The highest number of secreted (22%) and extracellular (4%) proteins was associated with MV proteinaceous cargo obtained from K59-68 grown in BHI to the midexponential phase.
Gene functional enrichment analyses for strain DO identified 10 functional annotation clusters in MV-associated proteins from exponential growth conditions in BHI and 16 functional annotation clusters in MV-associated proteins from stationary growth phase in LB. The difference in cluster number is probably due to the lower protein number in exponential growth phase (for empai > 1 n protein = 138) compared to stationary growth phase (for empai > 1 n protein = 258). The analysis showed that ribosomal, ATP synthesis, and membrane proteins were enriched in both exponential and stationary growth phase derived MVs in DO. The gene ontology enrichment analysis is illustrated in Fig. 6. 
Presence of virulence factors, vaccine candidates, and antimicrobial resistance-related proteins among the E. faecium MV-associated proteins
Fifteen distinct E. faecium genes encoding virulence factors, associated with biofilm formation and adherence, were identified within the genomes of the 4 examined strains: atlA [32] , acm [33, 34] , bepA [35] , capD [36] , ccpA [37, 38] , ecbA [39] , esp [40] , fnm [41] , pilA2 [42] , pilB/ ebp fm [43] , ptsD [44] , prpA [45] , sagA [46] [47] [48] , scm [49] and sgrA [39] . gelE [50] was also searched for but was absent in the selected genomes.
Presence or absence of selected virulence factors associated with the E. faecium-derived MVs is indicated in Table 2 . Proteomic analysis demonstrated the absence of BepA, EcbA, PilB/Ebp fm and SgrA in the purified MVs. Interestingly, the two biofilm determinants, namely AtlA and SagA, were found to be associated with MVs of all tested strains under both conditions. The adhesins Acm and CapD as well as the catabolite protein CcpA were also associated with purified MVs of all examined strains. Esp, an enterococcal surface protein enhancing biofilm formation, Fnm, a fibronectin-binding protein, PilA2, a pilus protein, PrpA, an extracellular matrix binding protein, PtsD, a phosphotransferase system protein, and the adhesin Scm, were associated with MVs from some of the examined strains.
The search was expanded to further include the enterococcal bacteriocins EntA, EntP, EntB, EntL50 [51] , EntQ [52] , Bac32 [53] and 
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Bac43 [54] . Out of those, only the gene entA was present in all the four genomes used in this study, but EntA was not found to be associated with the E. faecium derived MVs. As previous studies have identified putative enterococcal vaccine targets, the following candidates were searched for in the vesicular proteome: PsaA, AdcA [55] , PBP5, LysM, DdcP, PpiC [56] and SagA [48] (Table 2 ). PsaA and AdcA are both metal binding lipoproteins [55] , and PsaA was found associated with MVs from all four strains. PBP5, LysM, DdcP, and PpiC are putative surface-exposed proteins, which are associated with peptidoglycan [56] , and all four were found within all the examined MV samples. Additionally, SagA, which was present in all MV samples, was not only described as a virulence factor [46, 47] , but also as the first promising vaccine candidate in E. faecium, as it exhibited protective properties in a mouse model [48] .
Furthermore, resistance genes were identified in the four genomes using ResFinder [31] , and subsequently, the corresponding proteins were searched for in the MV proteomes ( Table 2 ). The protein Aph3′-III, a kanamycin kinase conveying resistance to aminoglycosides, was found in MV samples in both conditions. Aac6′-Ie-Aph2″-Ia, a bifunctional protein conferring broad-spectrum resistance to aminoglycosides such as gentamicin through N-and O-acetylation and phosphorylation of hydroxyl groups [57] , was associated with DO-, E155-and K59-68-derived MVs, isolated from BHI and/or LB cultures. ErmB, conferring macrolide, such as erythromycin, resistance, was associated with E155-and K60-39-derived MVs grown in LB to the stationary phase.
All proteins encoded by the vanA-cluster that contribute to glycopeptide resistance [58] were associated with E155-derived MVs grown in LB to the stationary growth phase: VanR-A, VanS-A, VanH-A, VanA, VanX-A, VanY-A, VanZ-A. A subset of those was also present in MVs isolated from exponential growth phase. Additionally, VanS-B encoded by the vanB-cluster was found associated with E155-derived MVs grown to the stationary growth phase. However, the E155 genome also encodes the rest of the genes of the vanB-cluster: vanR-B, vanY-B, vanW-B, vanH-B, vanB and vanX-B, but they were absent in the MVs ( Table 2) .
The macrolide resistance genes lnuB (K60-39) and msrC (all 4 strains) were present in the respective genomes but absent in the MVs. This also accounts for tetM (DO and K59-68) and dfrG (E155). Fig. 1 . E. faecium releases spherical MVs in vitro. A) TEM of MVs isolated from E. faecium E155 (the inset in the upper left corner shows the vesicle indicated by an arrow 2 times magnified). B) AFM of E. faecium E155 surrounded by MVs (the inset in the upper left corner shows the vesicle indicated by an arrow 2 times magnified). C) Abundance of the various sizes of purified MV from DO, E155, K59-68 and K60-39 grown to exponential phase in BHI as determined by DLS (mean in nm ± SD). D) MV-derived protein per CFU in DO, E155, K59-68 and K60-39 in cultures grown in BHI to OD 600 approximately 1.5. Fig. 2 . E. faecium MVs contain lipids and peptidoglycan. A) Confocal microscopy of MVs stained with lipid-tracer dye (DiD shown in red, the inset in the upper left corner shows the vesicle indicated by an arrow 2 times magnified). B) Fold changes in absorbance using anti-peptidoglycan antibodies in ELISA to detect peptidoglycan in bacteria and MVs isolated for the four strains at mid-exponential growth phase in BHI compared to the control (uncoated well). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Discussion
All cells investigated so far have been found to release vesicles, indicating a universal phenomenon. The release of bacterial membrane vesicles and their functional importance, including both offense and defense, has been widely studied in Gram-negative bacteria [59] . In recent years, vesicle research has also increased in Gram-positive bacteria such as Listeria [60] , Bacillus [16] , Staphylococcus [61] , Lactobacillus [62] , Streptococcus [63] and Clostridium [64] . Here we provide the first report describing MVs released by E. faecium.
Rivera et al. [16] observed spherically shaped vesicles with the size of 50-300 nm in B. anthracis. Similarly, MV isolated from Listeria, Staphylococcus, Lactobacillus, Streptococcus, and Clostridium ranged from 20 to 400 nm [60, 61, 63, 65] . The morphology of MVs secreted by E. faecium was found to be similar to the above-mentioned MVs from Gram-positive bacteria, both in terms of size and appearance (Fig. 1 , Table 1 ). We also quantified the vesicles based on protein measurement through Bradford reagent and found similar MV amounts produced by the four E. faecium strains. However, a drawback of these types of measurement approaches is the lack of a universal standard procedure for MV quantification. Until now, vesicular proteins have been quantified using protein-based (SDS-PAGE staining, Bradford reagent or bicinchoninic-acid assay BCA) and lipid-based (lipid probes such as FM4-64) approaches. However, all these methods have both strengths and weaknesses [66] . Moreover, for the proteomic analysis assessment of the purity of the MV sample is utmost important. Contaminating artifacts may co-pellet in the ultracentrifugation step of MV isolation. However, density gradient centrifugation was included in our study, which improves the purity of the MV sample [66, 67] .
As previously described in Gram-negative bacteria [68] and the Gram-positive bacterium Clostridium perfringens [64] , peptidoglycan was confirmed to be associated with enterococcal vesicles, through use of an antibody with specificity for the three-dimensional polymer complex structure of peptidoglycan. In addition, the MVs from all four strains exhibited negative surface charge, based on ζ-potential. The surface charge of Pseudomonas aeruginosa and B. anthracis derived MVs was also reported to be negative [16, 69] and in P. aeruginosa the ζ-potential was more negative in stationary growth phase derived vesicles compared to exponential growth phase [69] . Gram-positive and Gramnegative bacterial cells are negatively charged, too. It has been suggested that the charge is critical to understand the interaction between MVs and the bacterial cells [69] and the selectivity of this interaction since it was found that MVs are more likely to interact with bacterial cells of the parent species than of other genera [70] .
Besides the morphological characterization, a mass spectrometry based approach was used to gain insight into the proteomic profile of the isolated MVs. The overall proteomic pattern within MVs was similar regarding the percentage of proteins that derived from the core genome, their origin of localization, and whether they had a signal peptide or not (Figs. 3-5) . However, different numbers of MV-associated proteins identified by proteomics were found among the four examined strains and under varying conditions (Table 1, Fig. 3 ). Among Gram-positive bacteria substantially varying numbers of MV-associated proteins have been described previously, from 431 MV-associated proteins in C. perfringens grown in Trypticase-peptone-glucose broth [65] to 36 MV-associated proteins in B. anthracis 34F2 in BHI [16] . The growth medium affects the gene expression in bacteria which subsequently alters the amount and/or content of vesicles released into the growth medium [71] . Similarly, Bager et al. found significant changes in OMV production and protein composition upon altering medium composition in Gallibacterium anatis [72] . Moreover, a recent study on the proteome of Pseudomonas putida KT2440 by Choi et al. demonstrated that OMV production in LB media was three-fold higher than in two different minimal media containing succinate and benzoate [73] . Other previous studies identified a higher number of vesicular proteins in P. aeruginosa in LB compared to a more nutrient rich media [74] [75] [76] . Likewise, in our study, we observed a higher number of different proteins in MVs derived from E. faecium grown to stationary growth phase in nutrient-limiting LB compared to exponential growth in nutrient rich BHI. Under nutrient limitation and stationary growth, we expect the bacteria suffer more stress, which might explain more different vesicular proteins.
In the presented study we found a high abundance of cytoplasmic proteins, especially ribosomal proteins, which is similar to the number of cytoplasmic proteins encoded by the genome (Figs. 4, 6 ). This is in agreement with previous studies of MVs derived from Gram-positive bacteria [15, 19, 61] . This implicates, that the MV content represents basically the composition of the parent cell, even though final conclusions would require protein quantification rather than identification. We furthermore found, that high numbers of MV-associated proteins lack a secretion signal, which is in line with a previous study on S. aureus [21] as well as Campylobacter jejuni [77] and suggests that MVs may play an important role in the delivery of effector molecules, which lack a secretion signal.
As previous studies have shown that MVs of Gram-positive bacteria contain virulence factors [15, 16, 60, 78] , serve as vaccine candidates [79] and are contributing to antimicrobial resistance [80] , in silico methods were used to assess whether such factors are also associated with E. faecium MVs. Indeed, we identified 11 known virulence factors among the MV-associated proteins, including adhesins (CapD and PrpA), collagen-binding proteins (Acm and Scm), and fibronectinbinding protein (Fnm). These virulence factors are of particular importance for enterococcal adhesion, colonization and tissue invasion [34, 36, 41, 45, 49] . The association of collagen-binding proteins, as well as the fibronectin-binding protein and adhesins with MVs may suggest a role of the vesicles in enterococcal adhesion and colonization.
E. faecium utilizes biofilm formation as a survival strategy, which enables protection and persistence [81, 82] . Previous studies demonstrated that OMVs contribute to biofilm formation and stability [83, 84] . The virulence factors AtlA, Esp and SagA that contribute to enterococcal biofilm formation [32, 40, [46] [47] [48] were found to be MVassociated. This may suggest that E. faecium MVs can contribute to biofilm formation.
As highly stable, non-infectious, non-replicative particles vesicles are interesting vaccine candidates. Furthermore, they contain major immunogenic proteins of the MV producing bacterium that can act as antigens and thus can elicit responses in both arms of the immune system. Additionally, they display adjuvant activity (reviewed in [79, 85] ). The first OMV-based vaccine to be licensed for human use was the meningococcal serogroup B vaccine 4CMenB against the Gram-negative Neisseria meningitidis [86] . Also in the Gram-positive Streptococcus pneumoniae [87] and S. aureus [21, 88] , the protective effect of immunization with MVs was recently shown. For enterococci, there are to date no available vaccines, but there has been research towards identifying components for a vaccine to prevent E. faecium infection [48, 55, 56] . Here we found several previously described vaccine candidates to be associated with MVs (Table 2 ). However, whether enterococcal MVs can be used as vaccines remains to be investigated.
Special interest has been drawn to E. faecium due to their multidrug resistance and high genomic plasticity, which allows them to steadily acquire new resistance determinants. In the Gram-negative E. coli it was shown that OMVs not only have a protective role against membrane-active antimicrobials [80] , but also that certain antimicrobials increase the production of OMVs and OMV-associated Shiga toxin [89, 90] . Also resistancegenes were found to be transferred via OMVs [91] . Furthermore, OMVs of β-lactamase resistant Haemophilus influenzae and Moraxella catarrhalis were shown to protect Streptococcus pyogenes against amoxicillin [92] . Interestingly, our study demonstrates that both the ribosome methylase ErmB, the aminoglycoside modifying enzymes Aac6′-Ie-Aph2″-Ia and Aph3′-III as well as all proteins of the vanA vancomycin resistance cluster can be MV-associated in E. faecium. All these proteins mainly function inside the enterococcal cell. Thus they could potentially be active in creating antimicrobial resistance if they can be delivered to a recipient cell by the MVs. However, low empai values of the vanA-cluster encoded proteins, ErmB, Aac6′-Ie-Aph2″-Ia and Aph3′-III under the conditions studied here, suggest that these MVs do not have a great potential to cause antimicrobial resistance. Still, MV production and thus resistance-conferring proteins could be more abundant upon induction through antimicrobial stress as seen in MVs from Stenotrophomonas maltophilia [93] and E. coli [89] and then be presented in high enough concentrations to a recipient cell to confer an antimicrobial effect. This implicates that enterococcal MVs may play a role in antimicrobial resistance, not only for E. faecium itself but also for the bacterial community.
The mechanism of vesiculogenesis has not been conclusively clarified in Gram-positive bacteria. Recently, prophage-triggered MV formation was described and it has been postulated that phage endolysins may confer MV escape by locally digesting the cell wall [94] . Interestingly, by using PHASTER tool [95] , we detected phage genes within the genomes of DO, K59-68 and K60-39, but not in E155 (results not shown). Thus, prophages may play a role in the release of MV from certain strains. Apart from prophage-triggered MV formation, it has been suggested, that the vesicles passage the peptidoglycan layer with the aid of cell wall modifying enzymes such as peptidoglycan muramidases/ hydrolases, which are part of the Gram-positive type 4 secretion system (T4SS) [6, 15] . In the genomes of the four strains, we found T4SS using T346Hunter [96] (data not shown), suggesting that these strains might use components of this system for vesicle release. However, the mechanism for MV release in enterococci remains elusive. T. Wagner et al.
Journal of Proteomics xxx (xxxx) xxx-xxx
Conclusion
A proteomic approach was used to describe the protein cargo of membrane vesicles derived from four different, clinically relevant E. faecium strains under varying conditions. It was found that the MVassociated proteome is strain and condition dependent. The most interesting MV-associated proteins were the virulence factors and antimicrobial resistance related proteins. It is thus tempting to speculate that enterococcal MVs play an important role in infection and antimicrobial resistance. Our findings highlight the potential of bacterial MVs for research on bacterial pathogenesis.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.jprot.2018.05.017.
